Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 20, 2020 - Issue 6
Submit an article Journal homepage
930
Views
10
CrossRef citations to date
0
Altmetric
Review

Biologic therapies for the treatment of hidradenitis suppurativa

Monica Rosales SantillanHarvard Medical School and Clinical Laboratory for Epidemiology and Applied Research in Skin (CLEARS), Department of Dermatology, Beth Israel Deaconess Medical Center, Boston, MA, USAView further author information
,
Peyton C. MorssHarvard Medical School and Clinical Laboratory for Epidemiology and Applied Research in Skin (CLEARS), Department of Dermatology, Beth Israel Deaconess Medical Center, Boston, MA, USA;Medical School, University of Massachusetts, Worcester, MA, USAView further author information
,
Martina L. PorterHarvard Medical School and Clinical Laboratory for Epidemiology and Applied Research in Skin (CLEARS), Department of Dermatology, Beth Israel Deaconess Medical Center, Boston, MA, USAView further author information
&
Alexa B. KimballHarvard Medical School and Clinical Laboratory for Epidemiology and Applied Research in Skin (CLEARS), Department of Dermatology, Beth Israel Deaconess Medical Center, Boston, MA, USACorrespondence[email protected]
View further author information
Pages 621-633 | Received 15 Oct 2019, Accepted 18 Feb 2020, Published online: 06 Mar 2020

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Elisa Molinelli, Claudia Sapigni, Anna Campanati, Valerio Brisigotti & Annamaria Offidani. (2020) Metabolic, pharmacokinetic, and toxicological issues of biologic therapies currently used in the treatment of hidradenitis suppurativa. Expert Opinion on Drug Metabolism & Toxicology 16:11, pages 1019-1037.
Read now

Articles from other publishers (9)

Jill Hardin, Rupa Makadia, Shawn Black, Irene Lara-Corrales, Lucia Z. Diaz, Joslyn S. Kirby & Cynthia M.C. DeKlotz. (2023) Characteristics and treatment pathways in pediatric and adult hidradenitis suppurativa: An examination using real world data. JAAD International 12, pages 124-132.
Crossref
Laura Macca, Vittoria Moscatt, Manuela Ceccarelli, Ylenia Ingrasciotta, Giuseppe Nunnari & Claudio Guarneri. (2022) Hidradenitis Suppurativa in Patients with HIV: A Scoping Review. Biomedicines 10:11, pages 2761.
Crossref
Leah A. Johnston, Raed Alhusayen, Marc Bourcier, Isabelle Delorme, Ralph George, Elizabeth O’Brien, Se Mang Wong & Susan M. Poelman. (2022) Practical Guidelines for Managing Patients With Hidradenitis Suppurativa: An Update. Journal of Cutaneous Medicine and Surgery 26:2_suppl, pages 2S-24S.
Crossref
Khalaf Kridin, Kailyn Valido, Jeffrey M. Cohen & Arnon D. Cohen. (2022) Hidradenitis suppurativa and the risk of myocardial infarction, cerebrovascular accident, and peripheral vascular disease: a population-based study. Archives of Dermatological Research 315:3, pages 429-435.
Crossref
Adela Markota Čagalj, Branka Marinović & Zrinka Bukvić Mokos. (2022) New and Emerging Targeted Therapies for Hidradenitis Suppurativa. International Journal of Molecular Sciences 23:7, pages 3753.
Crossref
Manuel Batalla Sales, Gerard Pitarch Bort, María José Monedero Mira, Elena Ruiz Páez & Marta Ramos Bagán. (2022) Opciones terapéuticas de la hidradenitis supurativa en Medicina de Familia. FMC - Formación Médica Continuada en Atención Primaria 29:3, pages 143-150.
Crossref
Nadia Kashetsky, Asfandyar Mufti, Shaikhah Alabdulrazzaq, Yuliya Lytvyn, Muskaan Sachdeva, Abdullah Rahat & Jensen Yeung. (2021) Treatment Outcomes of IL-17 Inhibitors in Hidradenitis Suppurativa: A Systematic Review. Journal of Cutaneous Medicine and Surgery 26:1, pages 79-86.
Crossref
C.C. Zouboulis & A. Nogueira da Costa. (2020) Drug repurposing through drug–gene interaction profiles for hidradenitis suppurativa/acne inversa treatment. Journal of the European Academy of Dermatology and Venereology 35:4.
Crossref
Fenna M Jansen, Stephan R Vavricka, Alfons A Broeder, Elke MGJ Jong, Frank Hoentjen & Willemijn A Dop. (2020) Clinical management of the most common extra‐intestinal manifestations in patients with inflammatory bowel disease focused on the joints, skin and eyes. United European Gastroenterology Journal 8:9, pages 1031-1044.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.